Ameritox, Ltd. (Midland, Texas), a U.S. leader in pain prescription urine drug monitoring, announced its addition of an LC-MS-MS method for detecting prescription pain medications.
Ameritox, Ltd. (Midland, Texas), a U.S. leader in pain prescription urine drug monitoring, announced its addition of an LC-MS-MS method for detecting prescription pain medications.
"We are very pleased to be among the first pain medication monitoring laboratories to invest in this advanced LC-MS-MS multiplexing technology," said Dr. James Bourland, the laboratory director at Ameritox. "By converting two high-volume confirmations from GC-MS to multiplexing LC-MS-MS, Ameritox is able to provide even faster turn-around times as well as the most accurate and reliable analytical results to physician practices, which helps them provide better patient care."
